Loading clinical trials...
Loading clinical trials...
PHASE 2A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, INTRA-INDIVIDUAL COMPARISON TRIAL ASSESSING SAFETY, TOLERATION, PHARMACOKINETICS AND PILOT EFFICACY OF 4 WEEKS TREATMENT WITH TOPICAL CP-690,550 IN CHRONIC PLAQUE PSORIASIS
Conditions
Interventions
CP-690,550
CP-690,550
+6 more
Locations
20
United States
University of California Irvine
Irvine, California, United States
Therapeutics Clinical Research
San Diego, California, United States
RUSH University Medical Center
Chicago, Illinois, United States
Tufts Medical Center
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Start Date
October 13, 2008
Primary Completion Date
July 9, 2009
Completion Date
July 24, 2009
Last Updated
December 31, 2020
NCT06857942
NCT06979453
NCT07449234
NCT07116967
NCT07250802
NCT07449702
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions